These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 187150)

  • 1. Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.
    Cappel R
    Arch Virol; 1976; 52(1-2):29-35. PubMed ID: 187150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a nucleic acid free herpetic subunit vaccine.
    Cappel R; de Cuyper F; Rickaert F
    Arch Virol; 1980; 65(1):15-23. PubMed ID: 6252864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.
    Rosenberg GL; Farber PA; Notkins AL
    Proc Natl Acad Sci U S A; 1972 Mar; 69(3):756-60. PubMed ID: 4335071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type-2 glycoprotein-subunit vaccine: tolerance and humoral and cellular responses in humans.
    Mertz GJ; Peterman G; Ashley R; Jourden JL; Salter D; Morrison L; McLean A; Corey L
    J Infect Dis; 1984 Aug; 150(2):242-9. PubMed ID: 6088648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte stimulation by herpes simplex virus (HSV) antigens. 1. Culture conditions, cell fractionation and presentation of HSV antigens.
    Kapoor AK; Ling NR; Bazeley M
    Cytobios; 1977; 20(79-80):151-62. PubMed ID: 216529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection.
    Kumaraguru U; Gierynska M; Norman S; Bruce BD; Rouse BT
    J Virol; 2002 Jan; 76(1):136-41. PubMed ID: 11739679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.
    Irie H; Harada Y; Kataoka M; Nagamuta M; Moriya Y; Handa M; Saito M; Matsubara S; Kojima K; Sugawara Y
    J Virol; 1992 Apr; 66(4):2428-34. PubMed ID: 1312638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.
    Rajcáni J; Kutinová L; Vonka V
    Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.
    Zarling JM; Moran PA; Brewer L; Ashley R; Corey L
    J Virol; 1988 Dec; 62(12):4481-5. PubMed ID: 2846864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
    Klein RJ; Buimovici-Klein E; Moser H; Moucha R; Hilfenhaus J
    Arch Virol; 1981; 68(2):73-80. PubMed ID: 6264897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.
    Bernstein DI; Ashley RL; Stanberry LR; Myers MG
    J Clin Microbiol; 1990 Jan; 28(1):11-5. PubMed ID: 2153698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
    Carter CA; Hartley CE; Skinner GR; Turner SP; Easty DL
    Br J Ophthalmol; 1981 Oct; 65(10):679-82. PubMed ID: 6274376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
    Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge.
    Mishkin EM; Blasiak M; Giorgio D; Ishizaka ST
    Viral Immunol; 1992; 5(2):151-61. PubMed ID: 1319710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.